Addressing Sexual Health in Breast Cancer Survivors: Evidence-Based Practices and Clinical Considerations

Franzoi MA, Aupomerol M, Havas J, et al. Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomes. ESMO Open. 2024;9(2): 102236. https://doi.org/10.1016/j.esmoop.2024.102236.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flynn KE, Reese JB, Jeffery DD, et al. Patient experiences with communication about sex during and after treatment for cancer. Psychooncology. 2012;21(6):594–601. https://doi.org/10.1002/pon.1947.

Article  PubMed  Google Scholar 

Hanson A, Guglielmino J, Ormerod C, Katze N, Teteh D, Ericson M. Abstract PD8-07: the changing informational needs of young women affected by breast cancer: a national needs assessment. Cancer Res. 2023;83(5_Supplement):PD8-07. https://doi.org/10.1158/1538-7445.SABCS22-PD8-07.

McCallum M, Jolicoeur L, Lefebvre M, et al. Supportive care needs after gynecologic cancer: where does sexual health fit in? Oncol Nurs Forum. 2014;41(3):297–306. https://doi.org/10.1188/14.ONF.297-306.

Article  PubMed  Google Scholar 

Hill EK, Sandbo S, Abramsohn E, et al. Assessing gynecologic and breast cancer survivors’ sexual health care needs. Cancer. 2011;117(12):2643–51. https://doi.org/10.1002/cncr.25832.

Article  PubMed  Google Scholar 

Bober SL, Reese JB, Barbera L, et al. How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer. Curr Opin Support Palliat Care. 2016;10(1):44–54. https://doi.org/10.1097/SPC.0000000000000186.

Article  PubMed  PubMed Central  Google Scholar 

Reese JB, Sorice K, Beach MC, et al. Patient-provider communication about sexual concerns in cancer: a systematic review. J Cancer Surviv. 2017;11(2):175–88. https://doi.org/10.1007/s11764-016-0577-9.

Article  PubMed  Google Scholar 

Reese JB, Bauman JR, Sorice KA, Middleton D, McIlhenny S, Bober SL. Hematology and oncology fellow education about sexual and reproductive health: a survey of program directors in the United States. JCO. 2023;41(16_suppl):11029–11029. https://doi.org/10.1200/JCO.2023.41.16_suppl.11029.

Article  Google Scholar 

Carter J, Lacchetti C, Andersen BL, et al. Interventions to address sexual problems in people with cancer: American society of clinical oncology clinical practice guideline adaptation of cancer care Ontario guideline. J Clin Oncol. 2018;36(5):492–511. https://doi.org/10.1200/JCO.2017.75.8995.

Article  PubMed  Google Scholar 

Cathcart-Rake EJ, Ruddy KJ, Bleyer A, Johnson RH. Breast cancer in adolescent and young adult women under the age of 40 years. JCO Oncol Pract. 2021;17(6):305–13. https://doi.org/10.1200/OP.20.00793.

Article  PubMed  Google Scholar 

Yung RL, Gralow JR. Time to focus on breast cancer in young adults. JCO Oncol Pract. 2021;17(6):314–6. https://doi.org/10.1200/OP.20.01060.

Article  PubMed  Google Scholar 

Katz A, Agrawal LS, Sirohi B. Sexuality after cancer as an unmet need: addressing disparities, achieving equality. Am Soc Clin Oncol Educ Book. 2022;42:11–7. https://doi.org/10.1200/EDBK_100032.

Article  Google Scholar 

Kano M, Sanchez N, Tamí-Maury I, Solder B, Watt G, Chang S. Addressing cancer disparities in SGM populations: recommendations for a national action plan to increase SGM health equity through researcher and provider training and education. J Canc Educ. 2020;35(1):44–53. https://doi.org/10.1007/s13187-018-1438-1.

Article  Google Scholar 

Fehl A, Ferrari S, Wecht Z, Rosenzweig M. Breast cancer in the transgender population. J Adv Pract Oncol. 2019;10(4):387–94. https://doi.org/10.6004/jadpro.2019.10.4.6.

Article  PubMed  PubMed Central  Google Scholar 

Schröder CP, van Leeuwen-Stok E, Cardoso F, et al. Quality of life in male breast cancer: prospective study of the international male breast cancer program (EORTC10085/TBCRC029/BIG2-07/NABCG). Oncologist. 2023;28(10):e877–83. https://doi.org/10.1093/oncolo/oyad152.

Article  PubMed  PubMed Central  Google Scholar 

Lindau ST, Bensmaia SJ. Using bionics to restore sensation to reconstructed breasts. Front Neurorobot. 2020;14: 24. https://doi.org/10.3389/fnbot.2020.00024.

Article  PubMed  PubMed Central  Google Scholar 

Gass JS, Onstad M, Pesek S, et al. Breast-specific sensuality and sexual function in cancer survivorship: does surgical modality matter? Ann Surg Oncol. 2017;24(11):3133–40. https://doi.org/10.1245/s10434-017-5905-4.

Article  PubMed  Google Scholar 

Diao K, Lei X, He W, et al. Patient-reported quality of life after breast-conserving surgery with radiotherapy versus mastectomy and reconstruction. Ann Surg. 2023;278(5):e1096–102. https://doi.org/10.1097/SLA.0000000000005920.

Article  PubMed  Google Scholar 

Hanson SE, Lei X, Roubaud MS, et al. Long-term quality of life in patients with breast cancer after breast conservation vs mastectomy and reconstruction. JAMA Surg. 2022;157(6): e220631. https://doi.org/10.1001/jamasurg.2022.0631.

Article  PubMed  PubMed Central  Google Scholar 

Hammond JB, Kandi LA, Armstrong VL, et al. Long-term breast and nipple sensation after nipple-sparing mastectomy with implant reconstruction: relevance to physical, psychosocial, and sexual well-being. J Plast Reconstr Aesthet Surg. 2022;75(9):2914–9. https://doi.org/10.1016/j.bjps.2022.06.034.

Article  PubMed  Google Scholar 

Wei CH, Scott AM, Price AN, et al. Psychosocial and sexual well-being following nipple-sparing mastectomy and reconstruction. Breast J. 2016;22(1):10–7. https://doi.org/10.1111/tbj.12542.

Article  PubMed  Google Scholar 

Peled AW, Von Eyben R, Peled ZM. Sensory outcomes after neurotization in nipple-sparing mastectomy and implant-based breast reconstruction. Plast Reconstr Surg - Global Open. 2023;11(12): e5437. https://doi.org/10.1097/GOX.0000000000005437.

Article  Google Scholar 

Johnson MK, Cortina CS, Hsu TL, et al. National trends in “Going Flat” after mastectomy. Ann Surg Oncol. 2023;30(11):6374–82. https://doi.org/10.1245/s10434-023-13845-1.

Article  PubMed  Google Scholar 

Steffens D, Kappos EA, Lunger A, et al. The double S technique to achieve aesthetic flat closure after conventional mastectomy. World J Surg Onc. 2022;20(1):42. https://doi.org/10.1186/s12957-022-02515-3.

Article  Google Scholar 

Vegunta S, Kuhle CL, Vencill JA, Lucas PH, Mussallem DM. Sexual health after a breast cancer diagnosis: addressing a forgotten aspect of survivorship. JCM. 2022;11(22): 6723. https://doi.org/10.3390/jcm11226723.

Article  PubMed  PubMed Central  Google Scholar 

Weber WP, Shaw J, Pusic A, et al. Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy. The Breast. 2022;63:123–39. https://doi.org/10.1016/j.breast.2022.03.008.

Article  PubMed  PubMed Central  Google Scholar 

Baumgart J, Nilsson K, Evers AS, Kallak TK, Poromaa IS. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause. 2013;20(2):162–8. https://doi.org/10.1097/GME.0b013e31826560da.

Article  PubMed  Google Scholar 

Bernhard J, Luo W, Ribi K, et al. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. Lancet Oncol. 2015;16(7):848–58. https://doi.org/10.1016/S1470-2045(15)00049-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldberg C, Greenberg MR, Noveihed A, et al. Ovarian suppression: early menopause, late effects. Curr Oncol Rep. Published online January 2, 2024. https://doi.org/10.1007/s11912-023-01491-5.

FDA approves elacestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer | FDA. Accessed April 25, 2024. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-elacestrant-er-positive-her2-negative-esr1-mutated-advanced-or-metastatic-breast-cancer

Neupane N, Bawek S, Gurusinghe S, et al. Oral SERD, a novel endocrine therapy for estrogen receptor-positive breast cancer. Cancers. 2024;16(3): 619. https://doi.org/10.3390/cancers16030619.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shastry M, Hamilton E. Novel estrogen receptor-targeted agents for breast cancer. Curr Treat Options in Oncol. 2023;24(7):821–44. https://doi.org/10.1007/s11864-023-01079-y.

Article  Google Scholar 

Portman DJ, Gass MLS, Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. J Sex Med. 2014;11(12):2865–2872. https://doi.org/10.1111/jsm.12686.

Faubion SS, Larkin LC, Stuenkel CA, et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from the North

Comments (0)

No login
gif